Executive Management

"SMO-CLINICA results from the statement that Pharmas and Biotechs struggle developing new and effective therapies according to their strategic clinical development plan both in terms of timelines and budget, which is mainly due to the deficit of patients in Western countries. In that context, Emerging countries have a real card to play thanks to their large diversity of patient population and disease states. Whereas a significant number of Sponsors are still reluctant to go to Emerging Countries, SMO-CLINICA stands as the perfect answer to these companies since SMO-CLINICA do guaranty high standards of Quality and Ethics while leveraging access to patients in these new geographies. SMO-CLINICA’s goal is to set high standards for the Operations based on western management practices and client-oriented approach".

Jean-Claude Provost, MD
Co-Founder, Chairman

Dr Jean-Claude Provost has a considerable experience both in Clinical Research and management of companies.
Before founding SMO-CLINICA, Jean-Claude was CEO of CCBR, the division of Clinical Research Centres at Synarc-CCBR Inc. He previously held the position of Sr Vice President of Imaging Services & General Manager Europe at Synarc Inc.

Before joining Synarc, Jean-Claude was President & CEO of IôDP Medical Imaging Research, a company he sold to Synarc in 2004.
He previously occupied various positions in Clinical R&D Departments at Wyeth, Bayer and E.Merck.
Jean-Claude began his career as Research Physician in Clinical Pharmacology at St Antoine University Hospital in Paris.

Linda Pavis
Co-Founder, CEO

Before founding SMO-CLINICA, Linda Pavis spent seven years at Synarc Inc. having held different positions.

Linda first started as General Manager of the Paris Office and was then promoted to the position of Vice President of Sales, Business Development and Partnerships.
Before joining Synarc, Linda was Director of Sales & Marketing at IôDP Medical Imaging Research and played an active role in the sale of IôDP to Synarc Inc.

Linda began her career at Solvay and then joined Aster-Cephac (now SGS) as Business Development Executive.
To date, Linda cumulates an experience of over 12 years in Clinical Research.